Vera Therapeutics, Inc. - COMMON STOCK (VERA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
VERA on Nasdaq
Shares outstanding
64,326,281
Price per share
$50.64
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
65,067,827
Total reported value
$1,890,768,857
% of total 13F portfolios
0.01%
Share change
+801,757
Value change
+$37,111,876
Number of holders
173
Price from insider filings
$50.64
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vera Therapeutics, Inc. - COMMON STOCK (VERA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avoro Capital Advisors LLC 8.9% $134,640,000 5,610,000 Avoro Capital Advisors LLC 31 Dec 2024
PRICE T ROWE ASSOCIATES INC /MD/ 5.7% $106,551,338 3,666,598 T. Rowe Price Associates, Inc. 30 Sep 2025
Kynam Capital Management, LP 5.4% $83,444,698 3,426,887 Kynam Capital Management, LP 30 Jun 2025
Flynn James E 5.2% $75,299,151 3,348,117 Deerfield Mgmt, L.P. 06 Jun 2025

As of 30 Sep 2025, 173 institutional investors reported holding 65,067,827 shares of Vera Therapeutics, Inc. - COMMON STOCK (VERA). This represents 101% of the company’s total 64,326,281 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) together control 80% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Avoro Capital Advisors LLC 9.7% 6,210,000 -1.4% 2.3% $180,462,600
BlackRock, Inc. 6.6% 4,247,190 +2% 0% $123,423,343
Kynam Capital Management, LP 6.3% 4,027,800 +18% 8.7% $117,047,868
PRICE T ROWE ASSOCIATES INC /MD/ 5.7% 3,666,439 -18% 0.01% $106,547,000
DEERFIELD MANAGEMENT COMPANY, L.P. 5.7% 3,641,157 +8.8% 1.6% $105,812,022
VANGUARD GROUP INC 5% 3,190,653 +6.3% 0% $92,720,376
FMR LLC 4.4% 2,843,131 -2.3% 0% $82,621,388
Eversept Partners, LP 4.4% 2,807,836 +18% 6.2% $81,595,714
Sofinnova Investments, Inc. 4.3% 2,793,987 0% 5% $81,193,262
STATE STREET CORP 3.6% 2,333,583 +16% 0% $67,813,922
Integral Health Asset Management, LLC 2.6% 1,700,000 +48% 3.6% $49,402,000
CITADEL ADVISORS LLC 2.5% 1,615,338 +187% 0.04% $46,941,722
Pictet Asset Management Holding SA 2.2% 1,439,121 +86% 0.04% $41,820,856
TANG CAPITAL MANAGEMENT LLC 2.1% 1,350,000 0% 1.5% $39,231,000
GEODE CAPITAL MANAGEMENT, LLC 2.1% 1,321,575 +2.1% 0% $38,410,686
Point72 Asset Management, L.P. 2% 1,272,027 0.08% $36,965,112
Tri Locum Partners LP 1.9% 1,190,207 +188% 8% $34,587,415
Vestal Point Capital, LP 1.2% 760,000 -75% 1% $22,085,600
GOLDMAN SACHS GROUP INC 1.2% 758,566 +50% 0% $22,043,928
Woodline Partners LP 1.1% 737,578 -72% 0.1% $21,434,017
AMERICAN CENTURY COMPANIES INC 1.1% 708,423 -0.84% 0.01% $20,586,824
SCHRODER INVESTMENT MANAGEMENT GROUP 1.1% 679,992 +82% 0.02% $19,651,769
DEUTSCHE BANK AG\ 0.99% 633,820 +4.8% 0.01% $18,418,809
Rock Springs Capital Management LP 0.96% 617,396 0% 1% $17,941,528
MILLENNIUM MANAGEMENT LLC 0.93% 598,454 +173% 0.01% $17,391,073

Institutional Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 236,632 $11,983,451 -$10,685,992 $50.64 10
2025 Q3 65,067,827 $1,890,768,857 +$37,111,876 $29.06 173
2025 Q2 63,893,006 $1,505,324,602 +$17,298,219 $23.56 171
2025 Q1 62,915,975 $1,512,522,250 -$90,036,678 $24.02 176
2024 Q4 62,912,622 $2,660,465,176 +$389,856,746 $42.29 177
2024 Q3 53,519,938 $2,365,061,400 -$1,769,076 $44.20 172
2024 Q2 52,988,211 $1,917,110,562 +$57,678,654 $36.18 169
2024 Q1 51,298,718 $2,212,007,022 +$474,171,827 $43.12 157
2023 Q4 41,345,437 $635,880,813 +$44,778,975 $15.38 93
2023 Q3 39,258,779 $538,195,352 +$9,620,413 $13.71 84
2023 Q2 38,127,621 $611,912,465 +$42,587,635 $16.05 76
2023 Q1 37,354,429 $289,749,836 +$137,641,985 $7.76 69
2022 Q4 21,331,464 $412,748,829 -$7,253,468 $19.35 57
2022 Q3 21,539,667 $459,015,997 +$19,117,341 $21.31 55
2022 Q2 20,391,008 $277,615,038 +$7,846,841 $13.61 49
2022 Q1 19,483,745 $457,319,068 +$130,146,246 $23.49 49
2021 Q4 14,054,730 $374,899,000 +$10,499,638 $26.72 37
2021 Q3 14,710,587 $252,433,000 +$4,174,540 $17.35 30
2021 Q2 14,513,290 $186,104,000 +$186,104,000 $13.25 21